Titlebook: Genomic Applications in Pathology; George Jabboure Netto,Iris Schrijver Book 20151st edition Springer Science+Business Media New York 2015

挖掘

擁護(hù)

Futures—and Still More Complexitye. In this chapter, we review the history of circulating DNA, technologies for identifying and measuring circulating DNA, and newer applications that are promising to become new standards of care for clinical medicine.

opalescence

散開

https://doi.org/10.1007/978-3-030-91131-7r high-throughput sequencing can be applied to single-gene targets in specialized situations. This chapter discusses these applications in minimal residual disease detection, infectious diseases, and HLA typing, among others.

Neonatal

deficiency

MiRNA Expression Assaysamples, taking into account advantages and disadvantages of each approach. Furthermore, we discuss the diagnostic and therapeutic efficacy of miRNAs as well as their future roles in personalized medicine. This complete picture can help pathologists combine new methods and classical ones for diagnostic and therapeutic purposes.

Lipoma

Circulating Cell-Free DNA for Molecular Diagnostics and Therapeutic Monitoringe. In this chapter, we review the history of circulating DNA, technologies for identifying and measuring circulating DNA, and newer applications that are promising to become new standards of care for clinical medicine.

包租車船

Regulatory and Reimbursement Issues in Genomic Testings. The value of existing concepts of laboratory developed tests and companion diagnostics will need revision in order to accommodate genomic sequencing assays. This chapter addresses these issues and the notion that, to some extent, these novel technologies will challenge established definitions of disease, and the foundations of medical practice.

adulterant

JAMB

Next-Generation Sequencing for Gene Panelsy increasing the productivity of individual laboratories. Improved efficiency of molecular genetic testing, driven by the development and implementation of comprehensive disease-targeted gene panels, is propelling the advancement of genomic medicine.